Natus Medical EBITDA Margin Trend

Natus Medical Incorporated -- USA Stock  

USD 40.45  0.35  0.87%

This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 142, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 30.0252. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed EBITDA Margin of Natus Medical Incorporated with missing and latest data points interpolated. Measures the ratio between a company's Earnings Before Interest Taxes and Depreciation Amortization EBITDA and Revenues.
EBITDA Margin  10 Years Trend  
Increasing
Slightly volatile
 EBITDA Margin 
      Timeline 

Natus Medical EBITDA Margin Over Time

2015-12-31  0.18 
2016-12-31  0.19 
2017-12-31  0.19 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  0.12
Geometric Mean  0.095981
Coefficient Of Variation  77.76
Mean Deviation  0.069739
Median  0.16
Standard Deviation  0.094977
Sample Variance  0.009021
Range  0.32
R Value  0.45
Mean Square Error  0.007929
R Squared  0.2
Significance  0.14
Slope  0.011808
Total Sum of Squares  0.099227

Currently Trending

AJRD   
 NYQ 
Purchased over 90 shares of
few hours ago ago
Traded for 34.4
I   
 NYQ 
Purchased over 90 shares of
few hours ago ago
Traded for 6.4
CBAY   
 NCM 
Purchased over 90 shares of
few hours ago ago
Traded for 8.14